Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical Approaches [0.03%]
colorectal cancer肝转移的手术与非手术治疗进展：评述
I Valle,C Conticello,D Ravizza et al.
I Valle et al.
Colorectal liver metastases pose a significant clinical challenge for the multidisciplinary team (MDT), with the phenomenon of disappearing liver metastases (DLMs) following chemotherapy adding further complexity. DLMs, defined as the radio...
Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists [0.03%]
术后胸腺上皮肿瘤的临床靶区定义——英国临床肿瘤学家实践指南
S D Robinson,P Bhatnagar,R Duerden et al.
S D Robinson et al.
Background: Thymic epithelial tumours (TETs) are rare tumours, and most patients undergo curative resection. A minority require post-operative radiotherapy (PORT); however, current published guidelines provide differing r...
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Pancreatobiliary Cancer [0.03%]
立体定向体部放射治疗在寡转移性胰胆管癌中的应用
A N Mian,S Myrehaug,S Ng et al.
A N Mian et al.
Aims: In an oligometastatic disease, stereotactic body radiotherapy (SBRT) is being increasingly used in many different histologies to delay progression. However, by virtue of pancreatobiliary cancers not being as common ...
CAR-T in Central Nervous System Tumours: Promising Science, Slow Clinical Progress [0.03%]
嵌合抗原受体T细胞在中枢神经系统肿瘤中的应用：充满希望的科学，缓慢的临床进展
M Mehfooz,H Raza,A Javed et al.
M Mehfooz et al.
Disparity in Cancer Screening Among Black and Other Ethnic Minority Groups in the UK [0.03%]
英国黑人及其他少数族裔人群癌症筛查的差异性分析
Z Iyizoba-Ebozue,K Njoku,A Fatimilehin et al.
Z Iyizoba-Ebozue et al.
Establishing a National SABR Service: A Model for Safe and Effective Clinical Implementation [0.03%]
建立国家SABR服务：安全有效的临床应用模式
P Díez,R Patel,A Haridass et al.
P Díez et al.
Aims: Following the successful completion of a registry-based evaluation study of patients with extracranial oligometastatic disease or hepatocellular carcinoma treated with stereotactic ablative body radiotherapy (SABR),...
Response to the Letter (CLINONC-2025-990) Regarding Our Study on Functional Outcomes in Extremity Soft Tissue Sarcoma Survivors [0.03%]
关于我科四肢软组织肉瘤幸存者功能预后研究的回信
R G Hikmet,L B J Thorsen,H K Rose et al.
R G Hikmet et al.